Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEVI STRAUSS & CO Director's Dealing 2021

Mar 15, 2021

30653_dirs_2021-03-15_0a952198-7d25-47e3-8bd6-2349e0c1d54a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEVI STRAUSS & CO (LEVI)
CIK: 0000094845
Period of Report: 2021-03-11

Reporting Person: Ellison Seth M. (EVP & Chief Commercial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-12 Class A Common Stock C 59571 $0.00 Acquired 159535 Direct
2021-03-12 Class A Common Stock S 82705 $25.04 Disposed 76830 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-11 Stock Appreciation Rights $6.10 M 79915 Disposed 2023-02-09 Class B Common Stock (79915) Direct
2021-03-11 Class B Common Stock $ M 79915 Acquired Class A Common Stock (79915) Direct
2021-03-11 Class B Common Stock $ D 51505 Disposed Class A Common Stock (51505) Direct
2021-03-11 Stock Appreciation Rights $6.90 M 55215 Disposed 2024-02-01 Class B Common Stock (55215) Direct
2021-03-11 Class B Common Stock $ M 55215 Acquired Class A Common Stock (55215) Direct
2021-03-11 Class B Common Stock $ D 36440 Disposed Class A Common Stock (36440) Direct
2021-03-11 Stock Appreciation Rights $9.60 M 43035 Disposed 2025-01-30 Class B Common Stock (43035) Direct
2021-03-11 Class B Common Stock $ M 43035 Acquired Class A Common Stock (43035) Direct
2021-03-11 Class B Common Stock $ D 30649 Disposed Class A Common Stock (30649) Direct
2021-03-12 Class B Common Stock $ C 59571 Disposed Class A Common Stock (59571) Direct

Footnotes

F1: Transaction pursuant to a previously established Rule 10b5-1 Plan.

F2: Represents the conversion of Class B Common Stock into Class A Common Stock held of record by the Reporting Person.

F3: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $24.50 to $25.25. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: The stock appreciation rights are performance stock appreciation rights that vested on January 30, 2019 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors, and are immediately exercisable.

F5: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F6: The original grant was for 147,240 SARs, of which 36,810 SARs were exercised. 25% of the SARs vested on February 1, 2018, and 1/3 of the remaining SARs vest annually beginning on February 1, 2019.

F7: 25% of the SARs vested on January 30, 2019, and 1/3 of the remaining SARs vest annually beginning on January 30, 2020.